The Vitals

FDA Proposes Rescheduling Hydrocodone

October 25, 2013
Facing pressure from both lawmakers and the Drug Enforcement Administration, FDA said Thursday (Oct. 24) that it plans to recommend moving hydrocodone combination products, like Vicodin, from Schedule III to the more restrictive Schedule II. FDA drug center chief Janet Woodcock said the agency plans to finalize its formal recommendation to HHS to reclassify the drug by early December. Woodcock also said FDA anticipates the National Institute on Drug Abuse will concur with the recommendation, which would lead to a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.